Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Another Drug for Parkinson's Gets Approval

    Another Drug for Parkinson's Gets Approval

    With a new drug on the market to treat PD symptoms, it's important to discuss why you might consider one drug over another.
    Learn more

  • Exercise Improves Cognition in Parkinson's Disease

    Exercise Improves Cognition in Parkinson's Disease

    Researchers investigated different exercise programs for the effect on cognitive function of those with PD.
    Learn more

  • What We Fund: Genetic Links, Young Blood and Big Data

    What We Fund: Genetic Links, Young Blood and Big Data

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
    Learn more

  • Drug Reverses 'Off' Periods in Phase III Trial

    Drug Reverses 'Off' Periods in Phase III Trial

    Sunovion Pharmaceuticals Inc. recently announced positive results of under-the-tongue apomorphine.
    Learn more

  • $24-Million Public-Private Partnership Expands Investigation of Parkinson's Disease

    $24-Million Public-Private Partnership Expands Investigation of Parkinson's Disease

    The Michael J. Fox Foundation, National Institutes of Health and five industry partners unite to find molecular difference in Parkinson's.
    Learn more

  • Seizure Medication May Help Movement Symptoms in Lewy Body Dementia

    Seizure Medication May Help Movement Symptoms in Lewy Body Dementia

    The trial is a first step to evaluate the safety and effectiveness of zonisamide for LBD.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.